| Dr Rajeev Batra, MD | |
|
11120 New Hampshire Ave Ste 300, Silver Spring, MD 20904-2680 | |
| (301) 593-9612 | |
| (301) 593-6290 |
| Full Name | Dr Rajeev Batra |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 34 Years |
| Location | 11120 New Hampshire Ave Ste 300, Silver Spring, Maryland |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003918228 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | D0050678 (Maryland) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Adventist Home Health Services | Silver spring, MD | Home health agency |
| Holy Cross Home Care And Hospice | Silver spring, MD | Home health agency |
| Holy Cross Hospital | Silver spring, MD | Hospital |
| Entity Name | Comprehensive Medical Care Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730502816 PECOS PAC ID: 3577794163 Enrollment ID: O20140325000060 |
News Archive
The Scripps Research Institute and the California Institute for Biomedical Research - two leading non-profit research organizations - today announced the signing of a strategic affiliation that combines the two organizations into a new biomedical research entity with the tools and know-how to rapidly translate its scientific discoveries into life-saving medicines for the public benefit.
NOXXON Pharma AG, the biopharmaceutical company focusing on the development of novel drugs based on its unique proprietary Spiegelmer® technology, today announced successful completion of the first phase I trial with its anti-inflammatory Spiegelmer® NOX-E36. This drug candidate will be developed for the treatment of complications of type 2 diabetes, preferentially diabetic nephropathy, but also others.
In recent years, evidence has shown that patients treated with selective cyclo-oxygenase-2 (COX-2) inhibitors are at increased risk of heart attack and death. COX-2 inhibitors are used primarily to treat pain and arthritis in patients at risk of gastrointestinal bleeding.
ERYTECH Pharma (Euronext Paris: FR0011471135 - ERYP), a French biopharmaceutical company that develops innovative treatments for acute leukemia and other oncology indications with unmet medical needs, provides an update on its development plans to broaden the scope of its lead product ERYASP into the large field of solid tumors and announces the launch of a Phase II study in pancreatic cancer.
Oregon once led the country in implementing Obamacare. Now it's just about dead last. Not one person has yet enrolled in the Cover Oregon insurance exchange -; a major embarrassment to state policymakers who early on had wholeheartedly embraced the Affordable Care Act even as other states tried their best to hinder it. ... The uncertainty is leading to fears that Oregonians whose plans have been canceled as of Dec. 31 will find themselves without affordable coverage when the new year begins (Winfield Cunningham, 11/26).
› Verified 2 days ago
| Entity Name | Vein And Leg Clinic Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982162392 PECOS PAC ID: 6901130749 Enrollment ID: O20190627000955 |
News Archive
The Scripps Research Institute and the California Institute for Biomedical Research - two leading non-profit research organizations - today announced the signing of a strategic affiliation that combines the two organizations into a new biomedical research entity with the tools and know-how to rapidly translate its scientific discoveries into life-saving medicines for the public benefit.
NOXXON Pharma AG, the biopharmaceutical company focusing on the development of novel drugs based on its unique proprietary Spiegelmer® technology, today announced successful completion of the first phase I trial with its anti-inflammatory Spiegelmer® NOX-E36. This drug candidate will be developed for the treatment of complications of type 2 diabetes, preferentially diabetic nephropathy, but also others.
In recent years, evidence has shown that patients treated with selective cyclo-oxygenase-2 (COX-2) inhibitors are at increased risk of heart attack and death. COX-2 inhibitors are used primarily to treat pain and arthritis in patients at risk of gastrointestinal bleeding.
ERYTECH Pharma (Euronext Paris: FR0011471135 - ERYP), a French biopharmaceutical company that develops innovative treatments for acute leukemia and other oncology indications with unmet medical needs, provides an update on its development plans to broaden the scope of its lead product ERYASP into the large field of solid tumors and announces the launch of a Phase II study in pancreatic cancer.
Oregon once led the country in implementing Obamacare. Now it's just about dead last. Not one person has yet enrolled in the Cover Oregon insurance exchange -; a major embarrassment to state policymakers who early on had wholeheartedly embraced the Affordable Care Act even as other states tried their best to hinder it. ... The uncertainty is leading to fears that Oregonians whose plans have been canceled as of Dec. 31 will find themselves without affordable coverage when the new year begins (Winfield Cunningham, 11/26).
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Rajeev Batra, MD 4001 Thistlebridge Way, Rockville, MD 20853-3234 Ph: (301) 924-4560 | Dr Rajeev Batra, MD 11120 New Hampshire Ave Ste 300, Silver Spring, MD 20904-2680 Ph: (301) 593-9612 |
News Archive
The Scripps Research Institute and the California Institute for Biomedical Research - two leading non-profit research organizations - today announced the signing of a strategic affiliation that combines the two organizations into a new biomedical research entity with the tools and know-how to rapidly translate its scientific discoveries into life-saving medicines for the public benefit.
NOXXON Pharma AG, the biopharmaceutical company focusing on the development of novel drugs based on its unique proprietary Spiegelmer® technology, today announced successful completion of the first phase I trial with its anti-inflammatory Spiegelmer® NOX-E36. This drug candidate will be developed for the treatment of complications of type 2 diabetes, preferentially diabetic nephropathy, but also others.
In recent years, evidence has shown that patients treated with selective cyclo-oxygenase-2 (COX-2) inhibitors are at increased risk of heart attack and death. COX-2 inhibitors are used primarily to treat pain and arthritis in patients at risk of gastrointestinal bleeding.
ERYTECH Pharma (Euronext Paris: FR0011471135 - ERYP), a French biopharmaceutical company that develops innovative treatments for acute leukemia and other oncology indications with unmet medical needs, provides an update on its development plans to broaden the scope of its lead product ERYASP into the large field of solid tumors and announces the launch of a Phase II study in pancreatic cancer.
Oregon once led the country in implementing Obamacare. Now it's just about dead last. Not one person has yet enrolled in the Cover Oregon insurance exchange -; a major embarrassment to state policymakers who early on had wholeheartedly embraced the Affordable Care Act even as other states tried their best to hinder it. ... The uncertainty is leading to fears that Oregonians whose plans have been canceled as of Dec. 31 will find themselves without affordable coverage when the new year begins (Winfield Cunningham, 11/26).
› Verified 2 days ago
Jyotsna Mareedu, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1500 Forest Glen Rd, Silver Spring, MD 20910 Phone: 301-754-7000 | |
Sean S Saedi, M. D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 12210 Plum Orchard Drive, Suite 212, Silver Spring, MD 20904 Phone: 301-593-6844 Fax: 301-593-3832 | |
Herman B Segal, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 8630 Fenton St Ste 1105, Silver Spring, MD 20910 Phone: 301-681-9095 Fax: 410-367-2114 | |
Anuradha A Arun, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 9801 Georgia Ave, Suite 224, Silver Spring, MD 20902 Phone: 301-593-9800 Fax: 301-593-1061 | |
Dr. Seife Yohannes, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1215 E West Hwy, #910, Silver Spring, MD 20910 Phone: 301-273-3068 | |
Patricia Keegan, Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 10903 New Hampshire Ave, Building 22, Room 2328, Silver Spring, MD 20903 Phone: 301-796-1387 |